CG Oncology Dividends and Buybacks
Dividend criteria checks 0/6
CG Oncology does not have a record of paying a dividend.
Key information
n/a
Dividend yield
-18.7%
Buyback Yield
| Total Shareholder Yield | -18.7% |
| Future Dividend Yield | 0% |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Payout ratio | n/a |
Recent dividend and buyback updates
No updates
Recent updates
Companies Like CG Oncology (NASDAQ:CGON) Are In A Position To Invest In Growth
Oct 04
CG Oncology: Promising Data, But Looks Expensive
Aug 26CG Oncology, Inc. (NASDAQ:CGON) Shares Could Be 42% Below Their Intrinsic Value Estimate
Jul 25CG Oncology Bringing Undervalued Innovation To Bladder Cancer
Jul 09CG Oncology: ASCO Play And Top-Line Data End Of 2024 Could Drive Further Value
May 06Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if CGON's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if CGON's dividend payments have been increasing.
Dividend Yield vs Market
| CG Oncology Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (CGON) | n/a |
| Market Bottom 25% (US) | 1.4% |
| Market Top 25% (US) | 4.2% |
| Industry Average (Biotechs) | 2.3% |
| Analyst forecast (CGON) (up to 3 years) | 0% |
Notable Dividend: Unable to evaluate CGON's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate CGON's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate CGON's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as CGON has not reported any payouts.